{"public_id":"cl_adcf15b3e5713a4d2343f36b650a0734","status":"active","superseded_by_public_id":null,"corpus_id":4902739,"text":"Performed and planned efforts at TRIUMF are presented as approaches intended to address the major development issues in the 225Ac-radiopharmaceutical field.","confidence":0.88,"paper":{"corpus_id":4902739,"title":"Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences","url":"https://sah.borca.ai/papers/4902739"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.88,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0edb848ef674fb8b7818d7bb046c24a5","name":"development issues","description":"The set of practical obstacles hindering widespread clinical use of 225Ac radiopharmaceuticals.","types":["problem set"],"url":"https://sah.borca.ai/concepts/co_0edb848ef674fb8b7818d7bb046c24a5"},{"public_id":"co_0fdde3df38b414edc0d2e50c0060d61d","name":"225Ac-radiopharmaceutical field","description":"The research and development area focused on radiopharmaceuticals containing actinium-225.","types":["research field"],"url":"https://sah.borca.ai/concepts/co_0fdde3df38b414edc0d2e50c0060d61d"},{"public_id":"co_fc7f02801a596a9851f3527b775e864b","name":"TRIUMF","description":"Canada's particle accelerator centre, where related performed and planned efforts are based.","types":["institution"],"url":"https://sah.borca.ai/concepts/co_fc7f02801a596a9851f3527b775e864b"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_adcf15b3e5713a4d2343f36b650a0734"}